Clinical trials: Accelerated Intimal Hyperplasia

Accelerated Intimal Hyperplasia

Single Ascending Dose (BMS-813160) Study

• Completed
• Age: 18 to 45 years
• Phase 1

The primary purpose of this study is to evaluate the safety and tolerability of single oral doses of BMS-813160 in healthy subjects

Trial name

NCT01049165

Testing

BMS-813160, [14C] BMS-813160

Where

United States

Volunteers

70 people, healthy volunteers welcome

Sponsor

Bristol-Myers Squibb